While emerging research explores potential anti-inflammatory properties of GLP-1 receptor agonists, tirzepatide has no FDA approval for autoimmune conditions such as rheumatoid arthritis, lupus, or inflammatory bowel disease
Curr Med Res Opin 24(10):29432952 Degen L, Oesch S, Matzinger D, Drewe J, Knupp M, Zimmerli F et al (2006) Effects of a preload on reduction of food intake by GLP-1 in healthy subjects
143 (eds Duarte, C
In order to protect cells against sulfite toxicity, SIR expression is rapidly upregulated in Arabidopsis and tomato in response to higher sulfite content, and accordingly SIR activity increases (Yarmolinsky et al., 2013)
But what many people dont realise is that the benefits of GLP-1 receptor agonists go beyond just helping you fit into smaller clothes or control blood sugar